Comorbidities in SARS-CoV-2 Patients: a Systematic Review and Meta-Analysis
COVID-19 has plagued the world since it was first identified in December 2019. Previous systematic reviews and meta-analysis were limited by various factors such as the usage of non-peer reviewed data and were also limited by the lack of clinical data on a global scale.
Guardado en:
Autores principales: | Wern Hann Ng, Thomas Tipih, Nigel A. Makoah, Jan-G Vermeulen, Dominique Goedhals, Joseph B. Sempa, Felicity J. Burt, Adam Taylor, Suresh Mahalingam |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
American Society for Microbiology
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/39924fddf2ca4f16bad6ecef04f89a7e |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Infectious Clones Produce SARS-CoV-2 That Causes Severe Pulmonary Disease in Infected K18-Human ACE2 Mice
por: Xiang Liu, et al.
Publicado: (2021) -
Death by SARS-CoV 2: a Romanian COVID-19 multi-centre comorbidity study
por: Anca Pantea Stoian, et al.
Publicado: (2020) -
Comorbidities in Obsessive-Compulsive Disorder Across the Lifespan: A Systematic Review and Meta-Analysis
por: Eesha Sharma, et al.
Publicado: (2021) -
Comparative systematic review and meta-analysis of reactogenicity, immunogenicity and efficacy of vaccines against SARS-CoV-2
por: Ian McDonald, et al.
Publicado: (2021) -
COVID-19 patients age, comorbidity profiles and clinical presentation related to the SARS-CoV-2 UK-variant spread in the Southeast of France
por: Johan Courjon, et al.
Publicado: (2021)